NovaLead Pharma to conduct clinical trials for repurposed drug for COVID-19 Press Trust of India May 21, 2020 The drug, code-named NLP21, is in human use for several years for its original approved usage without any side effects of concern
NovaLead Pharma to conduct Phase 3 trial for its repurposed anti COVID-19 drug EP News Bureau May 14, 2020 In a comparable viral assay study conducted by reputed laboratories in South Korea and United States, the drug, NLP21 has shown…
